Sudden death due to cardiac arrhythmias.

By H. Huikuri, A. Castellanos, R. Myerburg. New England Journal of Medicine, 2001

1,543 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/eba7fae74f245347373607f6ec8bd3fe1ed9be70

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Prediction of adverse cardiac events in emergency department patients with chest pain using machine learning for variable selection (2014, background): “Such a risk stratification tool would be useful for chest pain patients presenting to the ED [3].”
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (2008, background): “The major determinants of risk of sudden death are related more to the severity of the cardiac disease and less to the frequency or classification of ventricular arrhythmias.(127,128)”
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “procainamide, propafenone, ajmaline, flecainide) is not recommended.(1,269,271)”
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (2011, background): “fibrillation constitute about half the cases.(197) Whether the”
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “The decreasing age-adjusted CHD mortality does not imply a decrease in absolute numbers of cardiac or SCDs (18,19) because of the growth and aging of the United States and European populations and the increasing prevalence of chronic heart disease (20).”
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, background): “Prophylactic treatment with antiarrhythmic drugs is not indicated and may be harmful.(464,465) III B”
Epidemiology of Sudden Cardiac Death: Clinical and Research Implications (2008, background): “The most common clinical finding associated with sudden cardiac death is coronary artery disease (Figure 4) and approximately 80% of sudden cardiac deaths are attributed to this disease condition (5,8,21,22).”